UPDATE : Tuesday, October 23, 2018
FDA approves Pfizer’s Remicade biosimilar by Lee Han-soo 2017-12-14 17:16
Korea launches mobile hospital to deploy emergency medical aid by Marian Chu 2017-12-14 16:56
Hironic wins ministry certification for Q-Fit by Lee Han-soo 2017-12-14 15:14
University professors sign petition against abortion law by Marian Chu 2017-12-14 15:03
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market by Lee Hye-seon 2017-12-14 15:01
‘More accurate diagnosis of preeclampsia possible’ by Park Gi-taek 2017-12-14 11:38
‘New cancer drugs need 601 days to get insurance in Korea’ by So Jae-hyeon 2017-12-14 11:27
Samsung BioLogics’ 2nd factory gets European approval by Lee Han-soo 2017-12-14 10:52
Koreans in their 20s most susceptible to hepatitis A: study by Marian Chu 2017-12-13 18:18
MGmed to change name to Cancer Rop by Marian Chu 2017-12-13 18:14
[Column] Look ahead 10 years before investing by Song Hyoung-gon 2017-12-13 17:48
Syntekabio, CJ Healthcare agree to develop new drugs using AI by Lee Han-soo 2017-12-13 17:17
Daewoong’s liver drug Ursa to enter US market by So Jae-hyeon 2017-12-13 15:23
Janssen says its multiple myeloma drug combo halves death risk by Marian Chu 2017-12-13 15:22
FDA approves treatment for eosinophilic granulomatosis with polyangiitis by Lee Han-soo 2017-12-13 14:35
Celgene, Bluebird Bio’s CAR-T therapy proves 94% response in P1 study by Marian Chu 2017-12-13 14:30
AstraZeneca to test Imfinzi on lung cancer patients by Lee Hye-seon 2017-12-13 14:20
Wholesalers sweat over drug companies’ forceful sales by So Jae-hyeon 2017-12-13 11:33
Misdiagnosis of Segawa syndrome sparks public debate by Lee Han-soo 2017-12-13 11:26
Hanmi leads erectile dysfunction drug sales by Marian Chu 2017-12-12 17:49
Back to Top